Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis

BMC Medical Imaging

Table 2 Results for life-years gained and cost–benefit analysis with the different costs for mammography

Category	Total cost (USD)	YLG	ICER	Cost/death averted	Number screened/death averted
The private institution only screening mammography
Age 40–49 years	38,967,374	2466.14	15,800.95	496,078.17	1273.06
Age 50–59 years	38,585,063	2566.93	15,031.6	359,319	931.238
Government institution only screening mammography
Age 40–49 years	8,656,833	2466.14	3510.275	110,206.7	1273.06
Age 50–59 years	8,278,038	2566.93	3224.87	77,088.2	931.238
Screening mammography with 50% of women screened at government and 50% at a private institution
Age 40–49 years	24,014,173	2466.14	9737.55	305,714.92	1273.06
Age 50–59 years	23,633,597	2566.93	9206.93	220,085	931.238
Screening mammography with 90% of women screened at government and 10% at a private institution
Age 40–49 years	11,768,715	2466.14	4739.343	148,793.85	1273.06
Age 50–59 years	11,308,740	2566.93	4405.54	105,311.26	931.238

YLG years of life gained, ICER incremental cost-effectiveness ratio, USD United States Dollars

ISSN: 1471-2342